HK34295A - Controlled release pharmaceutical preparation and method for producing the same - Google Patents
Controlled release pharmaceutical preparation and method for producing the sameInfo
- Publication number
- HK34295A HK34295A HK34295A HK34295A HK34295A HK 34295 A HK34295 A HK 34295A HK 34295 A HK34295 A HK 34295A HK 34295 A HK34295 A HK 34295A HK 34295 A HK34295 A HK 34295A
- Authority
- HK
- Hong Kong
- Prior art keywords
- producing
- pharmaceutical preparation
- active substance
- controlled release
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1344633A JPH0674206B2 (ja) | 1989-12-28 | 1989-12-28 | 放出制御型製剤およびその製法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK34295A true HK34295A (en) | 1995-03-17 |
Family
ID=18370774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK34295A HK34295A (en) | 1989-12-28 | 1995-03-09 | Controlled release pharmaceutical preparation and method for producing the same |
Country Status (16)
Country | Link |
---|---|
US (1) | US5395628A (de) |
EP (1) | EP0436370B1 (de) |
JP (1) | JPH0674206B2 (de) |
KR (1) | KR950007206B1 (de) |
CN (1) | CN1048398C (de) |
AT (1) | ATE92312T1 (de) |
AU (1) | AU632643B2 (de) |
CA (1) | CA2033277C (de) |
DE (1) | DE69002604T2 (de) |
DK (1) | DK0436370T3 (de) |
ES (1) | ES2060074T3 (de) |
FI (1) | FI103475B (de) |
HK (1) | HK34295A (de) |
HU (1) | HU205712B (de) |
IE (1) | IE64310B1 (de) |
IL (1) | IL96707A0 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2659230A1 (fr) * | 1990-03-08 | 1991-09-13 | Rhone Poulenc Sante | Procede d'enrobage par un polymere ph sensible de principes actifs. |
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
JP3426230B2 (ja) * | 1991-05-20 | 2003-07-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 複数層の制御放出処方剤 |
KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
GB9117361D0 (en) * | 1991-08-12 | 1991-09-25 | Euro Celtique Sa | Oral dosage form |
US7070806B2 (en) * | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
CA2137265C (en) * | 1992-06-04 | 2003-10-28 | Sanjay Bhardwaj | Palatable pharmaceutical compositions |
SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
JPH072650A (ja) * | 1993-06-18 | 1995-01-06 | Tanabe Seiyaku Co Ltd | 放出部位制御型製剤 |
SG80553A1 (en) * | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
US5837379A (en) * | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
ES2129356B1 (es) * | 1997-03-26 | 2000-01-16 | Pierre Fabre Iberica S A | Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion. |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
US6485748B1 (en) | 1997-12-12 | 2002-11-26 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US6322819B1 (en) | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
US20070122481A1 (en) * | 1998-11-02 | 2007-05-31 | Elan Corporation Plc | Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer |
US20060240105A1 (en) * | 1998-11-02 | 2006-10-26 | Elan Corporation, Plc | Multiparticulate modified release composition |
EP1126826B3 (de) * | 1998-11-02 | 2019-05-15 | Alkermes Pharma Ireland Limited | Multipartikuläre zusammensetzung von methylphenidat mit modifizierter freisetzung |
US20090149479A1 (en) * | 1998-11-02 | 2009-06-11 | Elan Pharma International Limited | Dosing regimen |
US20090297597A1 (en) * | 1998-11-02 | 2009-12-03 | Gary Liversidge | Modified Release Ticlopidine Compositions |
CA2389235C (en) | 1999-10-29 | 2007-07-17 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
EP2283829A1 (de) | 2000-10-30 | 2011-02-16 | Euro-Celtique S.A. | Hydrocodon-Formulierungen mit gesteuerter Freisetzung |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
JP4390702B2 (ja) * | 2002-06-24 | 2009-12-24 | 株式会社Adeka | 難燃剤組成物及び該組成物を含有した難燃性樹脂組成物 |
US6913768B2 (en) * | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
US20080220074A1 (en) * | 2002-10-04 | 2008-09-11 | Elan Corporation Plc | Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same |
DE10304403A1 (de) * | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
FR2850577B1 (fr) | 2003-02-03 | 2005-04-15 | Ethypharm Sa | Particules enrobees a gout masque, leur procede de preparation et comprimes orodispersibles contenant lesdites particules |
MXPA05008193A (es) * | 2003-01-30 | 2006-05-25 | Ethypharm Sa | Particulas con revestimiento que oculta el sabor, proceso para la preparacion de las mismas y tabletas orodispersables que contienen dichas particulas revestidas. |
AU2004258949B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2004258944B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2004264939A1 (en) | 2003-08-11 | 2005-02-24 | Middlebrook Pharmaceuticals, Inc. | Robust pellet |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
CA2535780A1 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
AU2004273830B2 (en) | 2003-09-15 | 2011-03-24 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP2007517039A (ja) * | 2003-12-24 | 2007-06-28 | アドバンシス ファーマスーティカル コーポレイション | 変性放出製剤の吸収増強 |
EP1771158A4 (de) | 2004-07-02 | 2008-03-12 | Advancis Pharmaceutical Corp | Tablette für pulsierte abgabe |
US20060121112A1 (en) * | 2004-12-08 | 2006-06-08 | Elan Corporation, Plc | Topiramate pharmaceutical composition |
US20060134227A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
US20070298098A1 (en) * | 2005-02-16 | 2007-12-27 | Elan Pharma International Limited | Controlled Release Compositions Comprising Levetiracetam |
AU2006235483B2 (en) * | 2005-04-12 | 2010-11-25 | Elan Pharma International Limited | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
WO2007037790A2 (en) * | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Modified release famciclovir compositions |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US20090074872A1 (en) * | 2006-06-26 | 2009-03-19 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
ATE553754T1 (de) * | 2006-08-18 | 2012-05-15 | Evonik Roehm Gmbh | Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser |
JP5228359B2 (ja) * | 2007-04-12 | 2013-07-03 | ニプロ株式会社 | 主薬粒子及びその製造方法ならびに口腔内崩壊錠 |
KR101571179B1 (ko) * | 2008-01-10 | 2015-11-23 | 에보니크 룀 게엠베하 | 증가된 맥동성 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제 |
JP4864024B2 (ja) * | 2008-02-15 | 2012-01-25 | エスエス製薬株式会社 | 時限放出製剤 |
CN107625741A (zh) * | 2016-07-18 | 2018-01-26 | 北京科信必成医药科技发展有限公司 | 一种掩味包衣制剂及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
JPH0621066B2 (ja) * | 1984-03-14 | 1994-03-23 | 杏林製薬株式会社 | 3―イソブチリル―2―イソプロピルピラゾロ〔1,5―a〕ピリジンの徐放性医薬品組成物 |
DE3438291A1 (de) * | 1984-10-19 | 1986-04-24 | Röhm GmbH, 6100 Darmstadt | Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
JPH0794384B2 (ja) * | 1986-09-01 | 1995-10-11 | 帝国製薬株式会社 | 徐放性口腔内用製剤 |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
-
1989
- 1989-12-28 JP JP1344633A patent/JPH0674206B2/ja not_active Expired - Fee Related
-
1990
- 1990-12-11 AU AU67988/90A patent/AU632643B2/en not_active Ceased
- 1990-12-12 IE IE448390A patent/IE64310B1/en not_active IP Right Cessation
- 1990-12-18 IL IL96707A patent/IL96707A0/xx unknown
- 1990-12-21 AT AT90314148T patent/ATE92312T1/de not_active IP Right Cessation
- 1990-12-21 FI FI906344A patent/FI103475B/fi active IP Right Grant
- 1990-12-21 DE DE90314148T patent/DE69002604T2/de not_active Expired - Fee Related
- 1990-12-21 EP EP90314148A patent/EP0436370B1/de not_active Expired - Lifetime
- 1990-12-21 DK DK90314148.9T patent/DK0436370T3/da active
- 1990-12-21 ES ES90314148T patent/ES2060074T3/es not_active Expired - Lifetime
- 1990-12-27 KR KR1019900021997A patent/KR950007206B1/ko not_active IP Right Cessation
- 1990-12-27 CA CA002033277A patent/CA2033277C/en not_active Expired - Lifetime
- 1990-12-27 HU HU908477A patent/HU205712B/hu not_active IP Right Cessation
- 1990-12-28 CN CN90110262A patent/CN1048398C/zh not_active Expired - Fee Related
-
1992
- 1992-04-13 US US07/870,195 patent/US5395628A/en not_active Expired - Lifetime
-
1995
- 1995-03-09 HK HK34295A patent/HK34295A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR950007206B1 (ko) | 1995-07-04 |
HUT56267A (en) | 1991-08-28 |
EP0436370B1 (de) | 1993-08-04 |
AU6798890A (en) | 1991-07-04 |
FI103475B1 (fi) | 1999-07-15 |
HU908477D0 (en) | 1991-07-29 |
IE904483A1 (en) | 1991-07-03 |
IE64310B1 (en) | 1995-07-26 |
ES2060074T3 (es) | 1994-11-16 |
CA2033277C (en) | 1998-05-12 |
DE69002604T2 (de) | 1993-12-02 |
DK0436370T3 (da) | 1993-10-11 |
CN1048398C (zh) | 2000-01-19 |
JPH0674206B2 (ja) | 1994-09-21 |
EP0436370A1 (de) | 1991-07-10 |
CA2033277A1 (en) | 1991-06-29 |
US5395628A (en) | 1995-03-07 |
KR910011242A (ko) | 1991-08-07 |
HU205712B (en) | 1992-06-29 |
DE69002604D1 (de) | 1993-09-09 |
FI103475B (fi) | 1999-07-15 |
CN1052788A (zh) | 1991-07-10 |
FI906344A (fi) | 1991-06-29 |
JPH03204810A (ja) | 1991-09-06 |
FI906344A0 (fi) | 1990-12-21 |
IL96707A0 (en) | 1991-09-16 |
ATE92312T1 (de) | 1993-08-15 |
AU632643B2 (en) | 1993-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK34295A (en) | Controlled release pharmaceutical preparation and method for producing the same | |
DE68907762D1 (de) | Arzneizubereitung mit gesteuerter wirkstofffreisetzung und verfahren zu deren herstellung. | |
HUT59321A (en) | Process for producing pharmaceutical compositions having controlled release of active ingredient | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
EP1452172A3 (de) | Aus mehreren Einzeleinheiten zusammengesetztes pharmazeutisches Präparat. | |
ES2001897A6 (es) | Procedimiento para la fabricacion de una tableta de liberacion controlada | |
CA2193129A1 (en) | Transdermal drug delivery system | |
PH22119A (en) | Controlled release medical preparations | |
EP0616802A4 (de) | Orale zubereitung zur freisetzung im unteren verdauungstract. | |
GB2333042A (en) | Colonic delivery of weak acid drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091221 |